4//SEC Filing
Vetticaden Santosh 4
Accession 0001127602-11-016608
CIK 0000912183other
Filed
May 16, 8:00 PM ET
Accepted
May 17, 3:01 PM ET
Size
19.3 KB
Accession
0001127602-11-016608
Insider Transaction Report
Form 4
Vetticaden Santosh
SVP & Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2011-05-14+1,875→ 5,545 total - Exercise/Conversion
Common Stock
2011-05-15+2,237→ 7,782 total - Exercise/Conversion
Restricted Stock Units
2011-05-15−2,237→ 4,475 totalFrom: 2010-05-15→ Common Stock (2,237 underlying) - Award
Stock Options (Right to Buy)
2011-05-13+45,000→ 45,000 totalExercise: $34.80From: 2011-08-13Exp: 2021-05-13→ Common Stock (45,000 underlying) - Exercise/Conversion
Restricted Stock Units
2011-05-14−1,875→ 5,625 totalFrom: 2011-05-14→ Common Stock (1,875 underlying) - Award
Restricted Stock Units
2011-05-13+7,200→ 7,200 totalFrom: 2012-05-13→ Common Stock (7,200 underlying)
Footnotes (3)
- [F1]Option vests 6.25% quarterly over a four-year period.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Cubist common stock.
- [F3]The restricted stock units vest 25% annually over a four-year period, with the first 25% vesting one year after the grant date. The restricted stock units do not expire.
Issuer
CUBIST PHARMACEUTICALS INC
CIK 0000912183
Entity typeother
Related Parties
1- filerCIK 0001386932
Filing Metadata
- Form type
- 4
- Filed
- May 16, 8:00 PM ET
- Accepted
- May 17, 3:01 PM ET
- Size
- 19.3 KB